Value-based approaches to healthcare systems and pharmacoeconomics requirements in Asia: South Korea, Taiwan, Thailand and Japan.
Asian healthcare systems are very diverse, representing cultures, political systems and economies from more than 30 countries with varying histories. Despite the diversity in the region, there has been enormous growth in health economics and outcomes research since the beginning of the 21st century. Whilst Japan has seen very limited use of health technology assessment (HTA), South Korea, Taiwan and Thailand have had remarkable success in establishing government agencies for HTA, employing HTA concepts from the UK National Institute for Health and Clinical Excellence (NICE). These three countries are driven by the following common factors: (i) a desire to establish universal healthcare insurance coverage in their respective nations; (ii) the need for rational allocation of scarce resources; (iii) a desire for government to provide leadership in HTA; and (iv) availability of HTA professionals and faculties through international networks. The HTA models introduced by these three countries are both similar to and different from those of HTA agencies in Europe, but might work well as examples for other countries in the region.
Kamae
Isao
I
Japanese Pharmaceutical Manufacturer's Association (JPMA) Pharmacoeconomics Program, Graduate School of Health Management, Keio University, Fujisawa, Kanagawa, Japan. ikamae@sfc.keio.ac.jp
D003365:Costs and Cost Analysis; D003695:Delivery of Health Care / Q000191:economics*; D017850:Economics, Pharmaceutical; D006801:Humans; D019458:Insurance Coverage / Q000191:economics; D007564:Japan; D009313:National Health Programs / Q000191:economics; D016730:Program Development / Q000191:economics; D012051:Reimbursement Mechanisms / Q000458:organization & administration*; D056910:Republic of Korea; D013624:Taiwan; D013673:Technology Assessment, Biomedical / Q000191:economics* / Q000458:organization & administration*; D013785:Thailand